Bone loss in anorexia nervosa: Leptin, serotonin, and the sympathetic nervous system

Annals of the New York Academy of Sciences

Volumn 1211, Issue , 2010, Pages 51-65

  Kumar, Kevin K ^a   Tung, Stephanie ^b   Iqbal, Jameel ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anorexia nervosa; Bone loss; Leptin; Osteoblast; Serotonin

Indexed keywords

ANOREXIGENIC AGENT; CALCIUM; DOPAMINE; ESTROGEN; ETIDRONIC ACID; FOLLITROPIN; LEPTIN; LEPTIN RECEPTOR; NORADRENALIN; SEROTONIN; VITAMIN D;

ADRENERGIC SYSTEM; ANOREXIA NERVOSA; ARTICLE; BONE MASS; CARBOHYDRATE INTAKE; DYSPHORIA; FEEDBACK SYSTEM; FOOD INTAKE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; NEUROBIOLOGY; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; SIGNAL TRANSDUCTION; SUPPLEMENTATION;

EID: 78349252964     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05810.x     Document Type: Article

References (114)

1. Attia, E. 2010. Anorexia nervosa: current status and future directions. Annu. Rev. Med. 61: 425-435.
2. Abell, T.L. et al 1987. Gastric electromechanical and neurohormonal function in anorexia nervosa. Gastroenterology 93: 958-965.
3. Gross, K.B., K.M. Brough & P.M. Randolph 1986. Eating disorders: anorexia and bulimia nervosas. ASDC J. Dent. Child. 53: 378-381.
4. Kaye, W.H., J.L. Fudge & M. Paulus 2009. New insights into symptoms and neurocircuit function of anorexia nervosa. Nat. Rev. Neurosci. 10: 573-584.
5. Jimerson, D. & B. Wolfe 2006. Psychobiology of eating disorders in Annual Review of Eating Disorders, Part 2. Wonderlich, S., J., Mitchell, M. De Zwann, & H. Steiger, eds. 1-15 Radcliffe Publishing Ltd. Abingdon, UK
6. Phillips, M.L. et al 2003. Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol. Psychiatry 54: 504-514.
7. Phillips, M.L. et al 2003. Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol. Psychiatry 54: 515-528.
8. Gordon, I. et al 1997. Childhood-onset anorexia nervosa: towards identifying a biological substrate. Int. J. Eat. Disord. 22: 159-165.
9. Râstam, M. et al 2001. Regional cerebral blood flow in weight-restored anorexia nervosa: a preliminary study. Dev. Med. Child Neurol. 43: 239-242.
10. Uher, R. et al 2003. Recovery and chronicity in anorexia nervosa: brain activity associated with differential outcomes. Biol. Psychiatry 54: 934-942.
11. Havel, P.J. 2000. Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proc. Nutr. Soc. 59: 359-371.
12. Haluzikova, D. et al 2009. Serum concentrations of adipocyte fatty acid binding protein in patients with anorexia nervosa. Physiol. Res. 58: 577-581.
13. Margetic, S. et al 2002. Leptin: a review of its peripheral actions and interactions. Int. J. Obes. Relat. Metab. Disord. 26: 1407-1433.
14. Boden, G. et al 1996. Effect of fasting on serum leptin in normal human subjects. J. Clin. Endocrinol. Metab. 81: 3419-3423.
15. Considine, R. V. et al 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334: 292-295.
16. Oswal, A. & G. Yeo Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity (Silver Spring) 18: 221-229.
17. Lee, G. H. et al 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635.
18. Björbaek, C. et al 1998. Expression of leptin receptor isoforms in rat brain microvessels. Endocrinology 139: 3485-3491.
19. Hileman, S.M. et al 2002. Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology 143: 775-783.
20. Tartaglia, L.A. 1997. The leptin receptor. J. Biol. Chem. 272: 6093-6096.
21. Montague, C.T. et al 1997. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387: 903-908.
22. Caro, J.F. et al 1996. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348: 159-161.
23. Considine, R.V. et al 1995. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J. Clin. Invest. 95: 2986-2988.
24. Hassink, S.G. et al 1996. Serum leptin in children with obesity: relationship to gender and development. Pediatrics 98: 201-203.
25. Heymsfield, S.B. et al 1999. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282: 1568-1575.
26. Ghilardi, N. & R.C. Skoda 1997. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol. Endocrinol. 11: 393-399.
27. Banks, A.S. et al 2000. Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 275: 14563-14572.
28. Xu, A.W. et al 2007. Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes decreased pomc expression, mild obesity, and defects in compensatory refeeding. Endocrinology 148: 72-80.
29. Morris, D. L. & L. Rui 2009. Recent advances in understanding leptin signaling and leptin resistance. Am. J. Physiol. Endocrinol. Metab. 297: E1247-E1259.
30. Chen, H. et al 1996. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495.
31. Mercer, J.G. et al 1996. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 387: 113-116.
32. Thornton, J.E. et al 1997. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138: 5063-5066.
33. Schwartz, M.W. et al 1996. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 98: 1101-1106.
34. Cowley, M.A. et al 2001. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411: 480-484.
35. Figlewicz, D.P. & S.C. Benoit 2009. Insulin, leptin, and food reward: update 2008. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296: R9-R19.
36. DiLeone, R.J., D. Georgescu & E.J. Nestler 2003. Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sci. 73: 759-768.
37. Harris, G.C., M. Wimmer & G. Aston-Jones 2005. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437: 556-559.
38. Huszar, D. et al 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141.
39. Chen, A.S. et al 2000. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26: 97-102.
40. Balthasar, N. et al 2005. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123: 493-505.
41. Coll, A.P., I.S. Farooqi & S.O'Rahilly 2007. The hormonal control of food intake. Cell 129: 251-262.
42. Coll, A.P. et al 2008. SnapShot: the hormonal control of food intake. Cell 135: e1-e2.
43. Gropp, E. et al 2005. Agouti-related peptide-expressing neurons are mandatory for feeding. Nat. Neurosci. 8: 1289-1291.
44. Pinto, S. et al 2004. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304: 110-115.
45. Sternson, S.M., G.M. Shepherd & J.M. Friedman 2005. Topographic mapping of VMH -> arcuate nucleus microcircuits and their reorganization by fasting. Nat. Neurosci. 8: 1356-1363.
46. Tung, Y.C. et al 2008. Novel leptin-regulated genes revealed by transcriptional profiling of the hypothalamic paraventricular nucleus. J. Neurosci. 28: 12419-12426.
47. Holder, J.L. Jr., N.F. Butte & A.R. Zinn 2000. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum. Mol. Genet. 9: 101-108.
48. Michaud, J.L. et al 2001. Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum. Mol. Genet. 10: 1465-1473.
49. Michaud, J.L. et al 1998. Development of neuroendocrine lineages requires the bHLH-PAS transcription factor SIM1. Genes Dev. 12: 3264-3275.
50. Kaye, W.H. et al 1987. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. J. Clin. Endocrinol. Metab. 64: 203-208.
51. Lesem, M.D. et al 1994. Cerebrospinal fluid TRH immunoreactivity in anorexia nervosa. Biol. Psychiatry 35: 48-53.
52. Tran, P.V. et al 2006. Diminished hypothalamic bdnf expression and impaired VMH function are associated with reduced SF-1 gene dosage. J. Comp. Neurol. 498: 637-648.
53. Cao, L. et al 2010. Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition. Cell 142: 52-64.
54. Unger, T.J. et al 2007. Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J. Neurosci. 27: 14265-14274.
55. Yeo, G.S et al 2004. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat. Neurosci. 7: 1187-1189.
56. Fairbanks, L. et al 2001. Social impulsivity inversely associated with CSF 5-HIAA and fluoxetine exposure in vermet monkeys. Neuropsychopharmacology 24: 370-378.
57. Lesch, K. & U. Merschdorf 2000. Impulsivity, aggression, and serotonin: a molecular psychobiological perspective. Behav. Sci. Law 185: 581-604.
58. Mann, J.J. 1999. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 21: S99-S105.
59. Simansky, K.J. 1996. Serotonergic control of the organization of feeding and satiety. Behav. Brain Res. 73: 37-42.
60. Soubrie, P. 1986. Reconciling the role of central serotonin neurons in human and animal behavior. Behav. Brain Sci. 9: 319-364.
61. Fernstrom, J.D. & R.J. Wurtman 1972. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178: 414-416.
62. Kaye, W.H. 2003. Anxiolytic effects of acute tryptophan depletion in anorexia nervosa. Int. J. Eat. Disord. 33: 257-267.
63. Crisp, A.H. 1978. Disturbances of neurotransmitter metabolism in anorexia nervosa. Proc. Nutr. Soc. 37: 201-209.
64. Stanley, M., L. Traskman-Bendz & K. Dorovini-Zis 1985. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci. 37: 1279-1286.
65. Audenaert, K. 2003. Decreased 5-HT2a receptor binding in patients with anorexia nervosa. J. Nucl. Med. 44: 163-169.
66. Bailer, U.F. 2004. Altered 5-HT2A receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness. Neuropsychopharmacology. 29: 1143-1155.
67. Bailer, U.F. et al 2007. Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol. Psychiatry. 61: 1090-1099.
68. Bailer, U.F. et al 2005. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Arch. Gen. Psychiatry. 62: 1032-1041.
69. Frank, G.K. 2002. Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biol. Psychiatry. 52: 896-906.
70. Galusca, B. et al 2008. Organic background of restrictive-type anorexia nervosa suggested by increased serotonin 1A receptor binding in right frontotemporal cortex of both lean and recovered patients: [18F]MPPF PET scan study. Biol. Psychiatry. 64: 1009-1013.
71. Tiihonen, J. et al 2004. Brain serotonin 1A receptor binding in bulimia nervosa. Biol. Psychiatry. 55: 871-873.
72. Cloninger, C.R. et al 1994. The Temperament and Character Inventory (TCI): A Guide To Its Development and Use. St. Louis, MO Center for Psychobiology of Personality, Washington University.
73. Yadav, V.K. et al 2009. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138: 976-989.
74. Frank, G. 2005. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11C]raclopride. Biol. Psychiatry 58: 908-912.
75. Bergen, A. 2005. Association of multiple DRD2 polymorphisms with anorexia nervosa. Neuropsychopharmacology 30: 1703-1710.
76. Kaye, W.H., G.K. Frank & C. McConaha 1999. Altered dopamine activity after recovery from restricting-type anorexia nervosa. Neuropsychopharmacology 21: 503-506.
77. DeDeurwaerdere, P. et al 2004. Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J. Neurosci. 24: 3235-3241.
78. Di Matteo, V. et al 2000. Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin2C receptors. Brain Res. 865: 85-90.
79. Rask-Andersen, M. et al Molecular mechanisms underlying anorexia nervosa: focus on human gene association studies and systems controlling food intake. Brain Res. Rev. 62: 147-164.
80. Leibowitz, S.F., P. Roossin & M. Rosenn 1984. Chronic norepinephrine injection into the hypothalamic paraventricular nucleus produces hyperphagia and increased body weight in the rat. Pharmacol. Biochem. Behav. 21: 801-808.
81. Heal, D.J. et al 1998. Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. Int. J. Obes. Relat. Metab. Disord. 22(Suppl. 1): S18-S28; discussion S29.
82. Kaye, W.H. et al 1985. Disturbances of norepinephrine metabolism and alpha-2 adrenergic receptor activity in anorexia nervosa: relationship to nutritional state. Psychopharmacol Bull. 21: 419-423.
83. Kaye, W.H. et al 1985. Altered norepinephrine metabolism following long-term weight recovery in patients with anorexia nervosa. Psychiatry Res. 14: 333-342.
84. Kaye, W.H. et al 1984. Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch. Gen. Psychiatry. 41: 350-355.
85. Bartak, V. et al 2004. Basal and exercise-induced sympathetic nervous activity and lipolysis in adipose tissue of patients with anorexia nervosa. Eur. J. Clin. Invest. 34: 371-377.
86. Nedvidkova, J. et al 2004. Increased subcutaneous abdominal tissue norepinephrine levels in patients with anorexia nervosa: an in vivo microdialysis study. Physiol. Res. 53: 409-413.
87. Chatelain, P. et al 1992. Prevention of calcium overload and down-regulation of calcium channels in rat heart by SR 33557, a novel calcium entry blocker. Cardioscience 3: 117-123.
88. Nakagawa, K. et al 1987. Beta-adrenergic receptor in heart of starved rats. Endocrinol. Jpn. 34: 381-385.
89. Brooks, E.R., P.M. Howat & D.S. Cavalier 1999. Calcium supplementation and exercise increase appendicular bone density in anorexia: a case study. J. Am. Diet. Assoc. 99: 591-593.
90. Brotman, A.W. & T.A. Stern 1985. Osteoporosis and pathologic fractures in anorexia nervosa. Am. J. Psychiatry. 142: 495-496.
91. Nakahara, T. et al 2006. The effects of bone therapy on tibial bone loss in young women with anorexia nervosa. Int. J. Eat. Disord. 39: 20-26.
92. Salisbury, J.J. & J.E. Mitchell 1991. Bone mineral density and anorexia nervosa in women. Am. J. Psychiatry. 148: 768-774.
93. Oswiecimska, J. et al 2007. Skeletal status and laboratory investigations in adolescent girls with anorexia nervosa. Bone 41: 103-110.
94. Iqbal, J., L. Sun & M. Zaidi Commentary-FSH and bone 2010: evolving evidence. Eur. J. Endocrinol. 163: 173-176.
95. Milos, G. et al 2005. Cortical and trabecular bone density and structure in anorexia nervosa. Osteoporos. Int. 16: 783-790.
96. Angeli, A. et al 1972. Behavior of the circadian rhythm of adrenal cortex secretion in anorexia nervosa in relation to the duration of amenorrhea. Folia Endocrinol. 25: 153-160.
97. Bachrach, L. K. et al 1990. Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 86: 440-447.
98. Milos, G. et al 2007. Does weight gain induce cortical and trabecular bone regain in anorexia nervosa? A two-year prospective study. Bone 41: 869-874.
99. Ducy, P. et al 2000. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100: 197-207.
100. Takeda, S. et al 2002. Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305-317.
101. Rosen, C.J. 2009. Leptin's RIGHT turn to the brain stem. Cell Metab. 10: 243-244.
102. Iqbal, J. et al 2006. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc. Natl. Acad. Sci. USA 103: 14925-14930.
103. Sun, L. et al 2006. FSH directly regulates bone mass. Cell 125: 247-260.
104. Swerdloff, R.S., R.A. Batt & G.A. Bray 1976. Reproductive hormonal function in the genetically obese (ob/ob) mouse. Endocrinology 98: 1359-1364.
105. Devleta, B., B. Adem & S. Senada 2004. Hypergonadotropic amenorrhea and bone density: new approach to an old problem. J. Bone Miner. Metab. 22: 360-364.
106. Zainabadi, K. 2009. SirT1 regulates bone mass in vivo through regulation of osteoblast andosteoclast differentiation. PhD, MIT Boston
107. Cakir, I. et al 2009. Hypothalamic Sirt1 regulates food intake in a rodent model system. PLoS One. 4: e8322, 1-12.
108. Ramadori, G. et al SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity. Cell Metab. 12: 78-87.
109. Kalra, S.P., M.G. Dube & U.T. Iwaniec 2009. Leptin increases osteoblast-specific osteocalcin release through a hypothalamic relay. Peptides. 30: 967-973.
110. DeMambro, V.E. et al 2008. Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. Endocrinology 149: 2051-2061.
111. Setnick, J. Micronutrient deficiencies and supplementation in anorexia and bulimia nervosa: a review of literature. Nutr. Clin. Pract. 25: 137-142.
112. Weaver, K., J. Wuest & D. Ciliska 2005. Understanding women's journey of recovering from anorexia nervosa. Qual. Health Res. 15: 188-206.
113. Lee, N.K. et al 2007. Endocrine regulation of energy metabolism by the skeleton. Cell 130: 456-469.
114. Bruni, V., M.F. Filicetti & V. Pontello 2006. Open issues in anorexia nervosa: prevention and therapy of bone loss. Ann. N.Y. Acad. Sci. 1092: 91-102.